pembrolizumab
merck
['keytruda', 'head and neck']
#esmo22: outside liver cancer, keytruda notches key win in neoadjuvant setting but flops in head and neck tumors - 
Early Drug Development Group is a CRO specialized in the preclinical and early clinical development of novel leads in oncology.